View all services

Mergers & Acquisitions

Celgene Corporation Merger With Bristol-Myers Squibb

Celgene Corporation, an immunology pharmaceutical company, merged with Bristol-Myers Squibb (NYSE: BMY), a prescription-manufacturing pharmaceutical company, in a transaction valued at $74 billion.

Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.

Find more information here.

For further inquiries
Contact us
Contact us

Please complete this form to be contacted by a Morrow Sodali representative.